Clinical Trial Update: Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the efficacy and safety of BI 1356 in combination with metformin in patients with Type 2 diabetes. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 1356 (BI 1356)
• metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2012-02-20